Casas-González Patricia, García-Sáinz J Adolfo
Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Apartado postal 70-248, México, DF 04510, Mexico.
Eur J Pharmacol. 2006 Aug 7;542(1-3):31-6. doi: 10.1016/j.ejphar.2006.05.031. Epub 2006 May 27.
Phosphorylation of G protein-coupled receptors is one of the earliest events that regulate their function. Current evidence indicates that homologous desensitization of these receptors mainly involves G protein-coupled receptor kinases whereas in heterologous desensitization second messenger-activated kinases play key roles. Recent data show that transactivation of EGF (epidermal growth factor) receptors may also play a role in receptor phosphorylation. The role of this process was studied for the alpha1B-adrenoceptor phosphorylation induced by agents acting through different processes using inhibitors to block the EGF receptor transactivation process at different levels. Experiments were performed using transfected rat-1 fibroblasts that express alpha1B-adrenoceptors in a stably fashion. A metalloproteinase inhibitor, an anti-heparin-binding-EGF-selective antibody, and a selective EGF-receptor kinase inhibitor blocked the alpha1B-adrenoceptor phosphorylation induced by noradrenaline or endothelin-1. Our results indicate that shedding of heparin-binding-EGF, transactivation of EGF receptors plays a more general role in alpha1B-adrenoceptor phosphorylation than previously anticipated. It is possible that other receptors/channels could be modulated through a similar pathway.
G蛋白偶联受体的磷酸化是调节其功能的最早事件之一。目前的证据表明,这些受体的同源脱敏主要涉及G蛋白偶联受体激酶,而异源脱敏中第二信使激活的激酶起关键作用。最近的数据表明,表皮生长因子(EGF)受体的转活化也可能在受体磷酸化中起作用。使用抑制剂在不同水平阻断EGF受体转活化过程,研究了通过不同过程起作用的药物诱导的α1B-肾上腺素能受体磷酸化过程中这一过程的作用。实验使用稳定表达α1B-肾上腺素能受体的转染大鼠-1成纤维细胞进行。金属蛋白酶抑制剂、抗肝素结合EGF选择性抗体和选择性EGF受体激酶抑制剂可阻断去甲肾上腺素或内皮素-1诱导的α1B-肾上腺素能受体磷酸化。我们的结果表明,肝素结合EGF的脱落、EGF受体的转活化在α1B-肾上腺素能受体磷酸化中起的作用比以前预期的更普遍。其他受体/通道可能通过类似途径进行调节。